TITLE

LETTERS TO THE EDITOR

AUTHOR(S)
Haylor, John L.; Morcos, Sameh H.; Wang, Andrew; Schwab, Steven J.
PUB. DATE
November 2000
SOURCE
Kidney International;Nov2000, Vol. 58 Issue 5, p2239
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Comments of the issue concerning role of endothelium (ET) receptor antagonism on human contrast nephropathy. Increase of immunoreactive plasma ET-1; Prevention of human contrast nephropathy; Comparison of the pharmacokinetics of SB209670 and the placebo group.
ACCESSION #
5866282

 

Related Articles

  • Effects of connexin-mimetic peptides on nitric oxide synthase- and cyclooxygenase-independent renal vasodilation. De Vriese, An S.; Van De Voorde, Johan; Lameire, Norbert H. // Kidney International;Jan2002, Vol. 61 Issue 1, p177 

    Effects of connexin-mimetic peptides on nitric oxide synthase- and cyclooxygenase-independent renal vasodilation.. Background: Research on the physiological role of endothelium-derived hyperpolarizing factor (EDHF) is hampered by the persistent controversy on its nature and mechanisms of action,...

  • Endothelial function in proteinuric renal disease. Joles, Jaap A.; Stroes, Erik S.G.; Rabelink, Ton J. // Kidney International Supplement;Jul1999, Issue 71, pS-57 

    Investigates the endothelial function in proteinuric renal disease. Effect of l-arginine suppletion on endothelium-dependent vasodilation; Oxidation of lipoproteins in lysophosphatidylcholine formation; Benefits of antiproteinuric strategies on endothelial function.

  • Effect of Renal Impairment on the Pharmacokinetics of Cilostazol and its Metabolites. Mallikaarjun, S.; Forbes, W.P.; Bramer, S.L. // Clinical Pharmacokinetics;1999 Supplement, Vol. 37 Issue 6, p33 

    Objective: The pharmacokinetics of cilostazol were studied in patients with mild, moderate and severe renal impairment and in healthy volunteers after administration of 50mg single and multiple doses of cilostazol. Design: This was an open-label, single and multiple dose study administering 50mg...

  • Pharmacokinetics of Gepirone in Subjects with Normal Renal Function and in Patients with Chronic Renal Dysfunction. Dogterom, P.; Huisman, J.A.M.; Gellert, R.; Verhagen, A. // Clinical Drug Investigation;2002, Vol. 22 Issue 8, p513 

    Objective: To compare the pharmacokinetic profiles of gepirone and its main metabolites, 1-(2-pyrimidinyl)-piperazine (1-PP) and the 3′-hydroxy derivative (3′-OH-gepirone) after a single oral dose of gepirone extended-release (gepirone-ER) in subjects with normal renal function and...

  • Clinafloxacin Pharmacokinetics in Renal Patients. Randinitis, E.J.; Koup, J.R.; Rausch, G.; Bron, N.J.; Hounslow, N.J.; Vassos, A.B.; Sedman, A.J. // Drugs;Dec1999 Supplement 2, Vol. 58 Issue 6, p250 

    Determines the single dose pharmacokinetics of clinafloxacin in patients with various degrees of renal function. Materials and methods; Results and discussion.

  • Expression of the C-C chemokine receptor 5 in human kidney diseases1. Segerer, Stephan; Mack, Matthias; Regele, Heinz; Kerjaschki, Dontscho; Schlöndorff, Detlef // Kidney International;Jul1999, Vol. 56 Issue 1, p52 

    Expression of the C-C chemokine receptor 5 in human kidney diseases. Background.Chemokines are proteins that contribute to the migration of leukocytes to sites of tissue injury. CCR5 is a receptor for the C-C chemokine RANTES, which is expressed in inflammatory kidney diseases and transplant...

  • Nitric oxide and Bartter and Gitelman syndromes. Warnock, David G. // Kidney International;Sep2001, Vol. 60 Issue 3, p1197 

    Editorial. Focuses on the clinical manifestations of Bartter and Gitelman syndromes. Association of the syndromes with volume depletion and elevated plasma renin activity, angiotensin II generation, and the aldosterone excretion; Implications of human genetic disorders on the disease; Increase...

  • Erratum.  // American Journal of Nephrology;Jul2018, Vol. 47 Issue 6, p450 

    The article presents a correction to article "Paricalcitol, microvascular and endothelial function in non-diabetic chronic kidney disease: a randomized trial" which appeared in American Journal of Nephrology 2015.

  • Raised alpha-fetoprotein levels associated with minor congenital defect. Jandial, Vijay; Thom, Hazel; Gibson, Jane // British Medical Journal;7/3/1976, Vol. 2 Issue 6026, p22 

    Examines the level of alpha-fetoprotein (FP) in amunotic fluid associated with minor congenital defect in Scotland. Association of neural defects and abnormalities of the fetus with all cases of raised alpha-FP levels; Absence of hemoglobin F on the a-FP levels; Indication of high a-FP levels...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics